Jeil Pharma Holdings Balance Sheet Health
Financial Health criteria checks 5/6
Jeil Pharma Holdings has a total shareholder equity of ₩431.9B and total debt of ₩151.7B, which brings its debt-to-equity ratio to 35.1%. Its total assets and total liabilities are ₩881.9B and ₩449.9B respectively.
Key information
35.1%
Debt to equity ratio
₩151.71b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩49.69b |
| Equity | ₩431.94b |
| Total liabilities | ₩449.91b |
| Total assets | ₩881.86b |
Recent financial health updates
These 4 Measures Indicate That Jeil Pharma Holdings (KRX:002620) Is Using Debt Extensively
Feb 27
Jeil Pharma Holdings (KRX:002620) Has A Somewhat Strained Balance Sheet
Nov 23
Recent updates
Is Jeil Pharma Holdings Inc (KRX:002620) A Smart Choice For Dividend Investors?
Mar 25These 4 Measures Indicate That Jeil Pharma Holdings (KRX:002620) Is Using Debt Extensively
Feb 27What Percentage Of Jeil Pharma Holdings Inc (KRX:002620) Shares Do Insiders Own?
Jan 23Jeil Pharma Holdings (KRX:002620) Has Compensated Shareholders With A 56% Return On Their Investment
Dec 28Jeil Pharma Holdings (KRX:002620) Has A Somewhat Strained Balance Sheet
Nov 23Financial Position Analysis
Short Term Liabilities: A002620's short term assets (₩385.6B) exceed its short term liabilities (₩380.7B).
Long Term Liabilities: A002620's short term assets (₩385.6B) exceed its long term liabilities (₩69.3B).
Debt to Equity History and Analysis
Debt Level: A002620's net debt to equity ratio (23.6%) is considered satisfactory.
Reducing Debt: A002620's debt to equity ratio has increased from 13.8% to 35.1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable A002620 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: A002620 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 10.8% per year.